21 April 2025 in Archives of Breast Cancer
Background: Retrieval of less than three Sentinel lymph nodes (SLN) has been shown to be associated with decrease disease specific survival. We aimed to find if the real-world experience replicates the data. Methods: 529 patients with breast cancer (BC) who underwent sentinel lymph node biopsy (SLNB) from Jan 2010 to Dec 2014 were retrospectively reviewed. Data was analyzed using SAS 9.4 software. Chi square test was used if body mass index (BMI) influences the number of SLN retrieved and to detect difference between the variables of using blue dye and radioisotopes for detecting SLN. Results: Proportion of one, two and three or more SLN retrieval was 21, 35 and 44% respectively with the median number two. There was no difference in the number of lymph nodes retrieved if the radioisotope (RI) was used alone or in combination with blue dye (BD). P value of 0. 88. No change in median number of SLN retrieved in different quadrants of the breast was noted. We obtained body mass index (BMI) in 454 patients. The rate of more than two SLN retrieval in patients with normal BMI was 16%. In overweight 12% and obese 18%. We compared SLN= (one, two) vs. SLN= two + group which are crossed tabbed against three BMI categories of normal, overweight and obese. This was statistically significant, p-value of 0. 028. Conclusion: The real-world data suggest sub-optimal retrieval of number of median SLN compared to clinical trials. Higher BMI was associated with less than three SLN retrieved.
30 June 2025 in Journal of Surgical Oncology
Background: Wound protectors (WPs) have been shown to decrease postoperative wound complications, yet limited data exist supporting WP for pancreaticoduodenectomies, with limited uptake in practice. We evaluated the effect of WP in pancreaticoduodenectomies on surgical site infections (SSIs) and serious complications.Methods: Utilizing the National Surgical Quality Improvement Program database, we included patients undergoing pancreaticoduodenectomy between 2017 and 2021. Baseline demographics and complications were compared between WP and no WP cohorts. Multivariate logistic regression was performed to identify the effect of WP use on 30‐day complications and factors associated with WP use.Results: Of 20 960 patients, 6167 (29.4%) used a WP. WPs were more commonly used in lower ASA classes, more comorbid patients, and preoperative weight loss. WP use was associated with increased operative time but decreased length of stay, SSIs, organ space infection, pancreatic fistula, reoperation, and serious complication. WP was independently associated with decreased serious complication (aOR 0.80, p < 0.001) and SSI (aOR 0.57, p < 0.001). Factors associated with increased likelihood of WP use include preoperative weight loss, broad‐spectrum antibiotic use, absence of bleeding disorder and firmer pancreatic texture.Conclusion: WP use during pancreaticoduodenectomy is associated with decreased number of postoperative complications and SSI. Future prospective randomized studies should assess cost–benefit and barriers to use to increase uptake of WP use.